John Lewis of the Otago Daily Times reports that new, low-GI sugar is not the answer to New Zealand’s problems with obesity and diabetes, according to a leading expert.
Professor Jim Mann, of the University of Otago, has said that while the science behind the new low glycemic-index (GI) sugar is interesting, its makers’ claims of health benefits are premature.
An excerpt: (read in full here)
“Chelsea Sugar launched LoGiCane yesterday – a natural cane sugar refined in a way which makes it slower to digest, metabolise and absorb, providing longer-lasting energy and increasing feelings of fullness.
“The company claims LoGiCane provides consumers with a healthier choice without compromising on taste or texture.
“In a statement from Chelsea New Zealand, Dr Alan Barclay of the Glycemic Index Foundation said replacing white refined sugar with a healthier low GI sugar alternative could have significant benefits for public health.
…
“Prof Mann said there was no evidence to show LoGiCane sugar would provide any health benefits to New Zealanders, particularly those who had diabetes or were obese.”